NEBIVIB 2.5 NEBIVOLOL 2.5mg. IP

Nebivib 2.5 tablets contain Nebivolol 2.5 mg and are used to treat high blood pressure. Main uses: treatment of hypertension, to lower blood pressure; may be used alone or together with other blood pressure medicines as advised by a doctor; lowering blood pressure helps reduce the risk of stroke and heart attack as part of overall cardiovascular care; blood pressure control should go along with diet, exercise, salt restriction, smoking cessation and other measures advised by a doctor.

Common side effects of Nebivib 2.5 Tablet include headache; tiredness (fatigue); dizziness; nausea; trouble sleeping (insomnia); slow heart rate. Get medical help at once if you notice very slow heartbeat or heart block; worsening of heart failure with swelling or breathlessness; severe bronchospasm or breathing difficulty.

Each Nebivib 2.5 tablet contains Nebivolol 2.5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Nebivib 2.5 Tablet only as your doctor advises.

The MRP of Nebivib 2.5 Tablet is ₹88 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹67.05 and the PTS is ₹60.34.

Each Nebivib 2.5 tablet contains Nebivolol 2.5 mg. It comes in a pack of 10x10 (Blister).

Nebivolol works on the heart in a few ways. It slows the heart rate and reduces the force of each heartbeat, so the heart has less work to do. It also lowers the activity of renin and relaxes blood vessels, which reduces peripheral resistance. Together these actions bring down blood pressure and ease the load on the heart and circulation.

Must not be used in patients with severe bradycardia or heart block greater than first degree. Must not be used in patients with cardiogenic shock or decompensated cardiac failure. Must not be used in patients with sick sinus syndrome unless a permanent pacemaker is in place. Must not be used in patients with severe hepatic impairment or in any patient who is hypersensitive to any component of the product. Check with a doctor first if you have diabetes, asthma or any other breathing problem, thyroid disease or kidney problems. In diabetes, nebivolol may mask the symptoms of low blood sugar and may alter glucose levels, so blood sugar should be monitored. Do not stop the medicine suddenly if you have coronary artery disease.

Nebivib 2.5 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.